Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02238671 | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | GABAPENTIN | Human | No | Prescription | 1 | GABAPENTIN | 100 MG / CAP |
Cancelled Pre Market | 02238672 | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | GABAPENTIN | Human | No | Prescription | 1 | GABAPENTIN | 300 MG / CAP |
Cancelled Pre Market | 02238673 | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | GABAPENTIN | Human | No | Prescription | 1 | GABAPENTIN | 400 MG / CAP |
Cancelled Post Market | 00851922 | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | GEMFIBROZIL CAP 300MG | Human | No | Prescription | 1 | GEMFIBROZIL | 300 MG / CAP |
Cancelled Post Market | 00851930 | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | GEMFIBROZIL TAB 600MG | Human | No | Prescription | 1 | GEMFIBROZIL | 600 MG |
Application information
Related information
Contact us
Version 4.0.3